熱門資訊> 正文

AIMD、BCG和RENB均为上市前输家

2024-05-24 20:16

Ainos Inc(AIMD) 0
Renovaro Biosciences Inc. - Common Stock(RENB) 0
Verastem(VSTM) 0

Losers: Verastem (VSTM) -57% rallies on positive data for pancreatic cancer drug combo.
Sensei Biotherapeutics (SNSE) -39% presents promising clinical data from Phase 1 Dose Escalation study of SNS-101.
Summit Therapeutics (SMMT) -17% after late-stage data for lead asset.
Domo (DOMO) -13% after Q1 earnings release.
Workday (WDAY) -11% after Q1 earnings release.
Ainos (AIMD) -7%.
Auddia (AUUD) -7%.
Binah Capital Group (BCG) -7%.
Renovaro (RENB) -7%.
Intuit (INTU) -6% after Q3 earnings release.

More on pre-market losers & stocks.

RenovaroCube to acquire 100% ownership of Cyclomics
Financial information for Ainos
Financial information for Binah Capital Group, Inc.
Financial information for Renovaro Inc.
Compare metrics for AIMD to BCG, RENB

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。